Bayer AG

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Bayer  shareholders on Tuesday voted in favour of ratifying the executive board's business conduct during 2019, following a rebuke a year earlier.

Bayer board wins shareholder vote of approval at AGM

Bayer  on Tuesday faces its second annual investor reckoning over its handling of a wave of U.S. lawsuits claiming its glyphosate-based weedkillers cause cancer.

Bayer faces second investor reckoning over glyphosate litigation

Werner Enterprises

Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q1 2020 Results - Earnings Call Transcript

Financially Sound Bayer Can Handle Both Coronavirus Consequences And Roundup Lawsuit

Bayer said the economic downturn and the need to preserve cash means it is taking a tougher stance in talks to settle claims over accusations that its glyphosate-based weedkillers cause cancer, even as its earnings rose.

Bayer takes tough stance in glyphosate settlement talks due to downturn

Bayer (BAYRY) beats earnings estimates for the first quarter of 2019.

Bayer (BAYRY) Q1 Earnings Beat Estimates, Sales Rise Y/Y

Deutsche Telekom AG

thyssenkrupp AG

German companies including ThyssenKrupp, Salzgitter, Bayer, Covestro, E.ON, HeidelbergCement, Puma, Allianz and Deutsche Telekom have called for coronavirus-related state aid to be tied to climate action, daily Handelsblatt reported.

German companies call for COVID-19 aid to be tied to climate action

German drugs and pesticides company Bayer said the economic downturn due to the coronavirus has prompted it to take a tougher stance in talks to settle claims its glyphosate-based weedkillers cause cancer.

Bayer more stringent  in glyphosate settlement talks due to downturn

Bayer more stringent in glyphosate settlement talks due to downturn

Shareholder advisory groups are divided over whether to endorse the management and directors at German drugs and pesticides company Bayer , according to recommendations submitted by proxy voting firms.

Proxy advisers split over endorsing Bayer management at AGM

Talks between Bayer AG  and plaintiff lawyers to settle claims that the German company's glyphosate-based weedkillers cause cancer have been slowed by the coronavirus pandemic, Bayer's Chief Executive told daily Handelsblatt.

Bayer says glyphosate settlement talks delayed by coronavirus-Handelsblatt

Internal documents describe how to profit from farmer losses and desire to oppose some independent testing

Revealed: Monsanto predicted crop system would damage US farms

Bayer has been hit hard by the ongoing sell-off, but is this an opportunity for investors?

Is Bayer Stock a Buy ?

FUJIFILM Holdings Corp

Gilead Sciences

Mylan

Regeneron Pharmaceuticals

Roche Holding AG

Sanofi

These drugs could be key to staving off COVID-19 until a vaccine is developed.

All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them

Amneal Pharmaceuticals

Novartis

Teva Pharmaceutical

No, but doctors can still use the drugs despite limited evidence of their effectiveness.

Are Chloroquine and Hydrochloroquine Approved to Treat COVID-19?

Negotiations between Bayer AG and plaintiff lawyers to settle claims its glyphosate-based weedkillers cause cancer have been slowed by the coronavirus outbreak, according to the mediator in the talks.

Bayer mediator says glyphosate settlement talks slowed by coronavirus

U.S. listed shares of Bayer AG BAYRY, +1.08% rose 3% in trading on Thursday afternoon after it said it had donated three million tablets of Resochin, a chloroquine product, to the U.S.

Bayer donates chloroquine to U.S., to seek emergency use as COVID-19 treatment

Early studies have shown the decades-old drug holds promise for treating the disease caused by the novel coronavirus.

Bayer Is Donating Its Malaria Drug That Could Help Coronavirus Patients In The U.S.

Bayer AG has agreed on draft settlement terms with half a dozen law firms representing tens of thousands of plaintiffs alleging that its Roundup weedkiller causes cancer, the Wall Street Journal reported on Friday, citing people familiar with the matter.

Bayer inches toward glyphosate settlement: WSJ

Bayer: A Solid 5% Dividend Yield

Corteva Inc

Bayer AG's takeover of Monsanto has been beset by problems, and now a decades-long dominance of the $4 billion U.S. soybean seed market is under threat from rival Corteva Inc.

Bayer's top seed faces U.S. soybean challenge from Corteva

GW Pharmaceuticals

CAMBRIDGE, United Kingdom and READING, United Kingdom, March  02, 2020  (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (GW) and Bayer plc, the life science company, today announce that GW will regain exclusive UK commercialisation rights for Sativex® (delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)) from Bayer.

GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer

Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q4 2019 Results - Earnings Call Transcript

Bayer (BAYRY) beats earnings estimates in the fourth quarter of 2019.

Bayer (BAYRY) Q4 Earnings Beat Estimates, Sales Rise Y/Y

Bayer  said on Thursday it was targeting growth in adjusted core profit of 7% to 9.6% this year, driven by sales of agriculture products and pharmaceuticals, with only the upper end of that range meeting market projections.

Bayer aims for 7%-9.6% profit growth in 2020

News for Bayer AG Stock (BAYRY)